News Daily News As Amyloidosis Field Explodes, Physicians Need to Spot and Treat Todd Neale October 20, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2020 Shelley Wood January 31, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses Shelley Wood December 23, 2019
News Daily News Carpal Tunnel Linked to Higher Rates of Amyloidosis and Heart Failure L.A. McKeown July 02, 2019
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019
News Industry News FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis May 06, 2019